bioRxivCancer BiologyPreprint
Spatial patterns of APOBEC mutagenesis in the tumour microenvironment of Asian breast cancer
Zi-Ching TaniD, Yang Wu, Zhen Wei NeoiD, Mai Chan LauiD, Soo-Hwang Teo, Joe Poh Sheng YEONG, Siow-Wee Chang, Jia Wern PaniD
Abstract
A germline deletion of the coding region at the APOBEC3B (A3B) gene that is common in Asian and Oceanic populations has been found to be correlated with increased APOBEC mutagenesis, immune activation, and tumour heterogeneity in breast cancer. The mechanism by which A3B deletion and APOBEC mutagenesis induces immune activation in Asian breast cancers is still unclear, but has been thought to involve increased neoantigen burden. In this study, we investigated the mechanisms by which A3B deletion and APOBEC mutagenesis may lead to immune activation using Stereo-seq spatial transcriptomics of Malaysian triple-negative breast cancer (TNBC) tumours with and without the A3B deletion to examine the spatial expression patterns of APOBEC3A/B as well the spatial patterns of APOBEC-associated mutations and neoantigens. Unexpectedly, we found only limited associations between A3B deletion, APOBEC-associated neoantigens, and immune activation. Instead, we found strong spatial associations between mitochondrial APOBEC-associations mutations, the cGAS-STING pathway, and the NF-{kappa}B pathway. Our study thus supports a new model whereby APOBEC-mediated activation of the immune system does not occur via neoantigen presentation, but instead occurs via mitochondrial hypermutation that drives cGAS-STING activation of the NF-{kappa}B pathway. Our study may provide new insights into the spatial landscape of Asian breast tumours and the effect of germline A3B deletion and APOBEC mutagenesis on the tumour immune microenvironment.
- organism: human
- assay: spatial transcriptomics
- research focus: host-pathogen & immune response
- research focus: cell type annotation
- research focus: spatial domain detection
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Germline APOBEC3B deletion in Asian women increases somatic hypermutation in breast cancer that is associated with Her2 subtype, PIK3CA mutations, immune activation, and increased survival
J.-W. Pan, M. M. A. Zabidi, … S.-H. Teo·bioRxiv·Jun 4, 2020
- APOBEC mutagenesis inhibits breast cancer growth through induction of a T cell-mediated antitumor immune response
A. V. DiMarco, X. Qin, … J. V. Alvarez·bioRxiv·Feb 13, 2021
- APOBEC3 mutagenesis drives therapy resistance in breast cancer
Avantika Gupta, Andrea M. Gazzo, … Sarat Chandarlapaty·Nature GeneticsPeer-reviewed·May 16, 2025
- APOBEC3-driven neoantigen-rich cancers co-opt 1q23.3 amplification for tumor-intrinsic immune cloaking
Dhanusha Yesudhas, Bilal A. Lone, … Abdul Rouf Banday·bioRxiv·Jul 4, 2026
- APOBEC3B mRNA Expression in Breast Cancer Correlates with Genomic Mutational Signatures
Joel Pardo, Nuri A. Temiz, Douglas Yee·bioRxiv·Aug 24, 2026
- Genetic modifiers of APOBEC-induced mutagenesis
Tony M. Mertz, Elizabeth Rice-Reynolds, … Steven A. Roberts·Genome ResearchPeer-reviewed·Sep 1, 2023